Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yu-Chang Liu
Regorafenib Inhibits Tumor Progression Through Suppression of ERK/NF-κB Activation in Hepatocellular Carcinoma Bearing Mice
Bioscience Reports
Biochemistry
Cell Biology
Molecular Biology
Biophysics
Related publications
Sorafenib Increases Efficacy of Vorinostat Against Human Hepatocellular Carcinoma Through Transduction Inhibition of Vorinostat-Induced ERK/NF-κB Signaling
International Journal of Oncology
Cancer Research
Oncology
Monoacylglycerol Lipase Promotes Progression of Hepatocellular Carcinoma via NF-κB-mediated Epithelial-Mesenchymal Transition
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Suppression of NF-κB and NF-κB-Regulated Gene Expression by Apigenin Through IκBα and IKK Pathway in TRAMP Mice
PLoS ONE
Multidisciplinary
Leptin Inhibits Neutrophil Apoptosis in Children via ERK/NF-κB-Dependent Pathways
PLoS ONE
Multidisciplinary
Celastrol Inhibits IL-1β-induced Inflammation in Orbital Fibroblasts Through the Suppression of NF-κB Activity
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Polycythemia in Hepatocellular Carcinoma-Bearing B6C3F1 Mice.
Journal of Toxicologic Pathology
Forensic Medicine
Toxicology
Pathology
Bryostatin I Inhibits Growth and Proliferation of Pancreatic Cancer Cells via Suppression of NF-κB Activation
Tropical Journal of Pharmaceutical Research
Pharmacology
Pharmaceutical Science
Urotensin II Contributes to the Formation of Lung Adenocarcinoma Inflammatory Microenvironment Through the NF-κB Pathway in Tumor-Bearing Nude Mice
Oncology Letters
Cancer Research
Oncology
Zerumbone Inhibits Tumor Angiogenesis via NF-κB in Gastric Cancer
Oncology Reports
Medicine
Cancer Research
Oncology
